We are live on ! Find out more
SCNI

Scinai Immunotherapeutics
SCNI

14 hedge funds and large institutions have $789K invested in Scinai Immunotherapeutics in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

41% more capital invested

Capital invested by funds: $560K → $789K (+$229K)

0% more ownership

Funds ownership: 0% → 0% (+0%)

18% less funds holding

Funds holding: 17 → 14 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
14
Holders Change
-3
Holders Change %
-17.65%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
3
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Envestnet Asset Management
Envestnet Asset Management
Illinois
+$103K
2
TSS
Two Sigma Securities
New York
+$102K
3
ECM
ExodusPoint Capital Management
New York
+$65K
4
TPWA
TRUE Private Wealth Advisors
Oregon
+$39.2K
5
State Street
State Street
Massachusetts
+$12K

Top Sellers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
-$78K
2
VF
Virtu Financial
New York
-$49K
3
Citadel Advisors
Citadel Advisors
Florida
-$40K
4
Morgan Stanley
Morgan Stanley
New York
-$3.92K
5
Bank of America
Bank of America
North Carolina
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
1
State Street
Massachusetts
$200K +$12K +58 +7%
Envestnet Asset Management
2
Envestnet Asset Management
Illinois
$118K +$103K +500 New
TSS
3
Two Sigma Securities
New York
$116K +$102K +494 New
TPWA
4
TRUE Private Wealth Advisors
Oregon
$108K +$39.2K +190 +70%
Morgan Stanley
5
Morgan Stanley
New York
$103K -$3.92K -19 -4%
ECM
6
ExodusPoint Capital Management
New York
$74K +$65K +315 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$32K – – –
UBS Group
8
UBS Group
Switzerland
$16K +$9.29K +45 +167%
Credit Agricole
9
Credit Agricole
France
$10K – – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$6K – – –
NFG
11
Next Financial Group
Texas
$3K – – –
CAPTRUST Financial Advisors
12
CAPTRUST Financial Advisors
North Carolina
$2K – – –
JP Morgan Chase
13
JP Morgan Chase
New York
$1K +$619 +3 New
HF
14
HRT Financial
New York
– -$78K -356 Closed
VF
15
Virtu Financial
New York
– -$49K -223 Closed
Citadel Advisors
16
Citadel Advisors
Florida
– -$40K -181 Closed
GRP
17
Global Retirement Partners
California
– -$1K -5 Closed
Bank of America
18
Bank of America
North Carolina
– -$1K -4 Closed
Wells Fargo
19
Wells Fargo
California
– -$206 -1 -33%

SCNI Hedge Fund Activity: Q4 2021 in Review

14 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Scinai Immunotherapeutics (SCNI) for Q4 2021, worth a combined $789K — up 41% from $560K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of SCNI and 4 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $103K. The largest seller was HRT Financial, exiting entirely with an estimated $78K sold.

  • 14 institutional investors held Scinai Immunotherapeutics (SCNI) as of Q4 2021, down from 17 in Q3 2021.
  • Funds reported $789K of Scinai Immunotherapeutics stock for Q4 2021, up 41% quarter-over-quarter.
  • 4 funds opened new Scinai Immunotherapeutics positions in Q4 2021 and 7 closed out, a net change of -3 holders.
  • The largest Scinai Immunotherapeutics buyer in Q4 2021 was Envestnet Asset Management, an estimated $103K added.
  • The largest Scinai Immunotherapeutics seller in Q4 2021 was HRT Financial, an estimated $78K sold.

Based on aggregated 13F filings for Q4 2021.